Grantham, Mayo, Van Otterloo & Co. LLC

Position in ZTS — Zoetis Inc.

CIK 1352662 Boston, MA

Back to ZTS Full portfolio

Position in ZTS

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$743,391

-$479,491 QoQ

Shares Held

10,345

0.0% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#704

of 1,408 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZTS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Grantham, Mayo, Van Otterloo & Co. LLC holds $28,929,984 across 5 Drug Manufacturers - Specialty & Generic names. ZTS ranks #4 (2.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HLN	Haleon plc	1,486,022	$13,864,585
2	NBIX	Neurocrine Biosciences Inc	72,430	$12,207,352
3	UTHR	UNITED THERAPEUTICS Corp	3,277	$1,775,576
4	ZTS	Zoetis Inc. This page	10,345	$743,391
5	RDY	Dr Reddys Laboratories Ltd	23,401	$339,080

All Filings in ZTS

Export CSV

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$743,391	10,345	0.0%	Shares	Sole	2026-08-13
2026-03-31	$1,222,882	10,345	+13.1%	Shares	Sole	2026-05-14
2025-12-31	$1,150,623	9,145	+17.1%	Shares	Sole	2026-02-17
2025-09-30	$1,142,759	7,810	+14.9%	Shares	Sole	2025-11-13
2025-06-30	$1,060,460	6,800	+58.1%	Shares	Sole	2025-08-13
2025-03-31	$707,995	4,300	—	Shares	Sole	2025-05-14
No filing history on record for this holder in this stock.